Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008058 · ClinicalTrials.gov registry record
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 213
- Enrollment target
NCT02008058: Completed study, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT02008058 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 213 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008058 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 213 participants
- Enrollment target
Study Summary
This is a single-arm observational longitudinal study in of patients with metastatic castrate-resistant prostate cancer designed to assess the longitudinal trajectory of pain and other symptoms.
Primary Outcome
Determine the proportion of pain palliation responders and the proportion experiencing pain progression will be presented along with 95% confidence intervals.
Interventions
- BEHAVIORAL Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2014-01-23 |
| Est. Completion | 2017-09-30 |
What the finished NCT02008058 record still lists
NCT02008058 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02008058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02008058 about?
NCT02008058 is a clinical study titled "Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer". This is a single-arm observational longitudinal study in of patients with metastatic castrate-resistant prostate cancer designed to assess the longitudinal trajectory of pain and other symptoms.
What is the current status of trial NCT02008058?
This trial is currently completed. The enrollment target is 213 participants. The study started on 2014-01-23. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT02008058?
The interventions under investigation include: Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02008058?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI